The University of Medicine and Pharmacy "Iuliu Hațieganu" in Cluj-Napoca is participating in the development of the European Master in Neurotechnology, a new master's program created together with six other European universities, from the Netherlands, Spain, Germany, Turkey, France, and Iceland.

The program will include the study of brain-computer interfaces, devices and sensors used in neurological research, as well as artificial intelligence applied to neural data analysis, with applications in the diagnosis and rehabilitation of patients with neurological conditions. UMF "Iuliu Hațieganu" will contribute to the Clinical and Technology components of the master's.

The master's degree lasts two years, is taught in English, and international mobility is mandatory in the third semester; graduates will receive a joint diploma from the seven universities. The program received a positive assessment from the accreditation organization NVAO from the Netherlands and Flanders on September 16, 2026, with launch scheduled for the 2027-2028 academic year.

The master's is part of the NeurotechEU alliance, of which UMF "Iuliu Hațieganu" is a founding member and which will grow to ten universities on November 10, 2026, with the joining of Lithuanian University of Health Sciences. The alliance benefits from European funding of 14.3 million euros through Erasmus+, for the period 2023-2027.